Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class II · Moderate risk

Safe tussin PM

CGMP Deviations: Use of non-food grade lubricant in mixing vessel.

Ongoing cGMP deviation Denison Pharmaceuticals, LLC D-0775-2023
Class II · Moderate risk

Pin-Away PYRENTAL PAMOATE

CGMP Deviations: Use of non-food grade lubricant in mixing vessel.

Ongoing cGMP deviation Denison Pharmaceuticals, LLC NDC 70309-080-02 D-0774-2023
Class II · Moderate risk

Colic Calm

CGMP Deviations: Use of non-food grade lubricant in mixing vessel.

Ongoing cGMP deviation Denison Pharmaceuticals, LLC D-0773-2023
Class II · Moderate risk

Safe tussin DM

CGMP Deviations: Use of non-food grade lubricant in mixing vessel.

Ongoing cGMP deviation Denison Pharmaceuticals, LLC D-0772-2023
Class II · Moderate risk

Famotidine Tablets

Labeling: Label Error on Declared Strength: some cartons labeled and containing 20 mg may have an external label placed on the side of the carton indicating strength as 10 mg.

Terminated Labeling / mix-up Glenmark Therapeutics, Inc. NDC 72657-113-20 D-0939-2023
Class II · Moderate risk

Pyrazinamide

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Ongoing cGMP deviation RemedyRepack Inc. NDC 70518-2534-01 D-0578-2023
Class II · Moderate risk

Ketotifen Fumarate 0.025 %

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Ongoing cGMP deviation RemedyRepack Inc. NDC 70518-1142-00 D-0577-2023
Class II · Moderate risk

LORazepam Injection

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Terminated cGMP deviation RemedyRepack Inc. NDC 17478-0040-01 D-0576-2023

Recalls by year